Mr. Rav Mlait reports

CANNABIX TECHNOLOGIES ANNOUNCES DELIVERY OF MARIJUANA BREATH TEST (MBT) TO VIRGINIA BASED INDUSTRIAL MANUFACTURING CLIENT

Cannabix Technologies Inc. has commercially delivered its marijuana breath test products to a leading industrial manufacturing company with operations in the state of Virginia. The delivery was completed through an authorized reseller. The announcement highlights diverse industries that are adopting the company's non-invasive breath-based testing products to support workplace safety programs.

The client, which operates large-scale custom machinery fabrication, sought a scientifically grounded method to assess recent cannabis use among its work force amid growing concerns about tetrahydrocannabinol-related safety incidents and the limitations of traditional drug testing.

Manufacturing sector faces rising cannabis-related safety pressures

Industrial manufacturing environments -- particularly those involving production lines, machining, robotics, welding, electrical systems and material-handling equipment -- are among the most safety-sensitive workplaces in the United States. Employers across the sector report increasing challenges related to cannabis use, including:

• Higher rates of workplace injuries associated with safety-relevant reaction time and reduced situational awareness;
• Labour shortages, making it difficult to suspend or replace employees based solely on legacy drug tests;
• Outdated testing methods (urine and saliva) that detect cannabis exposure from days or weeks prior;
• Legal and policy conflicts resulting from state-level legalization of recreational and medical marijuana;
• Insurance and compliance pressures requiring clearer documentation of safety-relevant testing.

Manufacturing employers are especially impacted because they operate heavy equipment, must maintain strict safety programs and cannot rely on drug tests that fail to distinguish recent cannabis use from historical use.

MBT: a modern, non-invasive tool for detecting recent cannabis use

The Cannabix MBT system is designed to detect delta-9 THC -- the primary psychoactive compound in cannabis -- in breath within four hours of use, at levels above five picograms per litre. This short detection window aligns closely with the period most correlated with recent use effects, offering a valuable alternative to legacy drug tests that identify past consumption. The MBT includes Cannabix's proprietary breath collection unit and breath cartridge technologies to collect and preserve breath samples for laboratory analysis using gold standard liquid chromatography/mass spectrometry methods. This window aligns closely with recent use time frames, offering an actionable alternative to legacy tests that detect past exposure.

"As industrial workplaces evolve and cannabis use becomes increasingly commonplace, manufacturers require tools that deliver fairness and scientific relevance," said Rav Mlait, chief executive officer of Cannabix. "Our early delivery of the MBT system to a major manufacturing client in Virginia demonstrates the growing interest for accurate, non-invasive testing that focuses specifically on recent cannabis use. This news highlights the MBT's readiness for deployment across high-risk industries that cannot compromise on safety."

Strategic and investor-focused outlook

This delivery marks another step in Cannabix's commercialization strategy, reinforcing the company's competitive position within safety-sensitive industries. Industrial manufacturing represents a substantial near-term market opportunity due to:

• The sector's dependence on skilled labour operating high-risk equipment;
• Increased THC-related incidents reported across U.S. manufacturing work sites;
• Heightened insurance requirements and safety audits;
• A shift toward recent use testing tools rather than legacy exposure-based methods.

Cannabix is working to position the MBT as a new standard for detecting recent cannabis use across multiple safety-critical industries. The company believes the MBT platform is well positioned to become a new standard for detecting recent cannabis use among employers with safety-critical operations. Cannabix maintains a strategic partnership with Omega Laboratories Inc., a global leader in forensic drug testing for over 25 years, operating a fully accredited laboratory with extensive experience in novel drug detection technologies.

About Cannabix Technologies Inc.

Cannabix is a developer of marijuana and alcohol breath technologies for workplaces, law enforcement and other settings. The marijuana breath test targets delta-9 THC (the primary psychoactive ingredient in cannabis) in breath and focuses on recent marijuana use. Cannabix is the developer of the BreathLogix autonomous alcohol screening device for organizations which strive to improve alcohol safety and monitoring.

We seek Safe Harbor.